Competitive Enterprise Institute | 1899 L ST NW Floor 12, Washington, DC 20036 | Phone: 202-331-1010 | Fax: 202-331-0640
WASHINGTON, DC, October 5, 1998—A new nationwide poll of neurologists and neurosurgeons sponsored by the Competitive Enterprise Institute (CEI) finds that delays in FDA approval of new drugs and medical devices is viewed as a serious problem by a large majority of these specialists. "When so many doctors have such negative views of an agency ostensibly dedicated to promoting public health, it is clear that significant reform is needed," said CEI policy analyst Gregory Conko.
The poll will be released at a press conference at 10:00 AM on Thursday, October 8th, in room 311 of the Cannon House Office Building. Representatives Joe Barton (R-TX) and Peter DeFazio (D-OR), leaders in the FDA reform effort, will join CEI’s Sam Kazman and Gregory Conko at the event. Kellyanne Fitzpatrick and Jason Booms of the polling companyä , which conducted the poll, will also be on hand to answer questions.
Highlights of the poll include:
The survey included 202 respondents and has a +4.9 percent margin of error. Two previous CEI polls—one of cardiologists, completed in July 1996, and one of cancer specialists, completed in August 1995—found similar results on each of these points.
CEI, a non-profit, non-partisan public policy group founded in 1984, is dedicated to the principles of free enterprise and limited government. For more information, contact Emily McGee, director of public relations, at 202-331-1010.